Leef Brands (LEEEF) Equity Ratio (2024 - 2026)

Leef Brands' (LEEEF) quarterly Equity Ratio came in at 0.14 in Q1 2026, up 39.51% quarter-over-quarter from 0.23 in Q4 2025.

Leef Brands (LEEEF) Equity Ratio (2024 - 2026) Analysis & Trends

Leef Brands has disclosed Equity Ratio across 3 years of filings, most recently posting 0.14 for Q1 2026.

  • Equity Ratio for Q1 2026 came in at 0.14, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.14 (changed N/A YoY), and the FY2025 annual result was 0.23, up 21.49% from the prior year.
  • Equity Ratio came in at 0.14 for Q1 2026 at Leef Brands, up from 0.23 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.14 in Q1 2026 to a low of 0.29 in Q4 2024.
  • The 3-year median for Equity Ratio is 0.23 (2025), against an average of 0.22.
  • Peak annual rise in Equity Ratio reached 21.49% in 2025, while the deepest fall reached 21.49% in 2025.
  • Leef Brands' Equity Ratio stood at 0.29 in 2024, then grew by 21.49% to 0.23 in 2025, then jumped by 39.51% to 0.14 in 2026.
  • The last three Equity Ratio figures came in at 0.14 (Q1 2026), 0.23 (Q4 2025), and 0.29 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.21
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.21
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 0.88
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.73
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 0.69
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.49
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.41
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 0.20
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.52
10 Leef Brands - - 4.62 Mn -0.14

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.14
Dec 31, 2025 -0.23
Dec 31, 2024 -0.29